BLR Bio is structured around discovery and development of first-in-class technology to diagnose, prevent and treat fibrosis and related chronic diseases. Founder and principals of the firm are focused on renal/cardiovascular systems, skin scarring and the fibrosis that complicates diabetes. The technology uses the bodys defense system as a basis to create biologic therapies, activating cellular proteins or blocking their receptors when the patient is incapable of doing so. The objective is to treat in an affordable way, tthese major causes of morbidity and mortality
